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Summary Key Points 
• According to the most recent FluView report, influenza activity remains low in the 
United States overall. 
• So far, influenza A(H3N2) viruses have been most common this season. 
• Flu is difficult to predict. It’s not possible to say when the 2017-2018 flu season will 
begin in the United States, how severe it will be or what viruses will predominate. 
• Each flu season, flu causes millions of illnesses, hundreds of thousands of 
hospitalizations and thousands or sometimes tens of thousands of deaths. 
• The Centers for Disease Control and Prevention (CDC) recommends annual flu 
vaccination for everyone 6 months and older by the end of October, if possible. 
• CDC recommends injectable influenza vaccine this season (flu shots). 
• There is no preferential recommendation for one flu shot over another. 
• It takes about two weeks after vaccination for protection to set in.  
• Now is a good time to get vaccinated. 
• There are many reasons to get a flu vaccine. 
1. While flu vaccine can vary in how well it works, it is the best way to prevent 
flu illness and serious flu complications, including those that can result in 
hospitalization. 
2. Even with vaccine effectiveness in the range of 30 to 60 percent, flu 
vaccination prevents millions of illnesses and tens of thousands of flu-related 
hospitalizations each year. 
3. We cannot know which viruses will circulate over the season and which virus 
will predominate. Flu vaccine protects against three or four different flu 
viruses, depending on which vaccine you get.  
4. A 2017 study was the first of its kind to show that flu vaccination can 
significantly reduce a child’s risk of dying from influenza. 
5. Getting vaccinated yourself protects people around you, including those who 
are more vulnerable to serious flu illness, like babies and young children, 
older people, and people with certain chronic health conditions. 
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6. While flu vaccine is not perfect and some people who get vaccinated may still 
get flu, there is some data to suggest that flu vaccination may make illness 
milder. 
• Manufacturers report having shipped more than 130.2 million doses of flu vaccine 
as of October 20, 2017. 
• The total projected supply of vaccine in the United States this season is between 
151 million and 166 million doses of flu vaccine. About 119 million doses will be 
quadrivalent vaccine. 
• Go to https://vaccinefinder.org  or www.cdc.gov/flu  to find a location near you 
where you can get vaccinated. 
 
Flu Activity 
According to this week’s FluView report, seasonal influenza activity remains low overall in 
the United States. However, 4 states and Guam reported regional flu activity and 12 
states and Puerto Rico reported local influenza activity. Flu vaccine is the best available 
way to protect against influenza. CDC recommends that everyone 6 months and older get 
an injectable flu vaccine as soon as possible. Below is a summary of the key flu indicators 
for the week ending October 28, 2017: 
• Influenza-like Illness Surveillance: For the week ending October 28, the 
proportion of people seeing their health care provider for influenza-like illness (ILI) 
was 1.5% which is below the national baseline of 2.2%. All 10 regions reported a 
proportion of outpatient visits for ILI below their region-specific baseline levels. 
o Additional ILINet data, including national, regional, and select state-level 
data for the current and previous seasons, can be found at 
http://gis.cdc.gov/grasp/fluview/fluportaldashboard.html. 
 
• Influenza-like Illness State Activity Indicator Map: One state experienced 
moderate ILI activity (Wyoming). Four states (Georgia, Louisiana, South Carolina, 
and South Dakota) experienced low ILI activity. New York City and 45 states 
experienced minimal ILI activity. Data were insufficient to calculate an ILI activity 
level from the District of Columbia and Puerto Rico. 
o Additional data, including data for previous seasons, can be found at 
https://gis.cdc.gov/grasp/fluview/main.html  
 
• Geographic Spread of Influenza Viruses: Regional influenza activity was 
reported by Guam and four states (Georgia, Louisiana, Oklahoma, and Texas). 
Local influenza activity was reported by Puerto Rico and 12 states (Alaska, Arizona, 
California, Connecticut, Kentucky, Maine, Massachusetts, Mississippi, New Mexico, 
Ohio, South Carolina, and Tennessee). Sporadic activity was reported by the 
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District of Columbia and 31 states (Alabama, Arkansas, Colorado, Delaware, 
Florida, Hawaii, Idaho, Indiana, Illinois, Iowa, Kansas, Maryland, Michigan, 
Minnesota, Missouri, Montana, Nebraska, Nevada, New Jersey, New York, North 
Carolina, North Dakota, Oregon, Pennsylvania, South Dakota, Utah, Vermont, 
Virginia, Washington, Wisconsin, and Wyoming). No activity was reported by one 
state (Rhode Island). The U.S. Virgin Islands and two states (New Hampshire and 
West Virginia) did not report. Geographic spread data show how many areas within 
a state or territory are seeing flu activity. 
o Additional data are available at: 
https://gis.cdc.gov/grasp/fluview/FluView8.html.   
 
• Flu-Associated Hospitalizations: Reporting of influenza-associated 
hospitalization data from the Influenza Hospitalization Surveillance Network 
(FluSurv-NET) for the 2017-2018 influenza season will begin later this season. 
o Additional data, including hospitalization rates during other influenza seasons, 
can be found at http://gis.cdc.gov/GRASP/Fluview/FluHospRates.html and 
http://gis.cdc.gov/grasp/fluview/FluHospChars.html.  
 
• Mortality Surveillance:  
o The proportion of deaths attributed to pneumonia and influenza (P&I) was 5.6% 
for the week ending October 14, 2017 (week 41). This percentage is below the 
epidemic threshold of 6.2% for week 41 in the National Center for Health 
Statistics (NCHS) Mortality Surveillance System.  
o Region and state-specific data are available at 
https://gis.cdc.gov/grasp/fluview/mortality.html.     
 
• Pediatric Deaths:  
o One influenza-associated pediatric death that occurred during the 2016-2017 flu 
season was reported to CDC during the week ending October 28, 2017 (week 
43). 
o This death was associated with an influenza A (H3) virus and occurred during 
week 7 (the week ending February 18, 2017). This death brings the total 
number of reported influenza-associated pediatric deaths occurring during 
2016-2017 season to 109. 
o One influenza-associated pediatric death for the 2017-2018 season has been 
reported to CDC. 
o Additional information on pediatric deaths is available on FluView Interactive at: 
https://gis.cdc.gov/GRASP/Fluview/PedFluDeath.html.  
 
• Laboratory Data:  
o Nationally, the percentage of respiratory specimens testing positive for influenza 
viruses in clinical laboratories during the week ending October 28 was 2.9%. 
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o Regionally, the three week average percent of specimens testing positive for 
influenza in clinical laboratories ranged from 0.4% to 5.7%. 
o During the week ending October 28, of the 336 (2.9%) influenza-positive tests 
reported to CDC by clinical laboratories, 228 (67.9%) were influenza A viruses 
and 108 (32.1%) were influenza B viruses. 
o The most frequently identified influenza virus type reported by public health 
laboratories was influenza A virus.   
o During the week ending October 28, 109 (91.6%) of the 119 influenza-positive 
tests reported to CDC by public health laboratories were influenza A viruses and 
10 (8.4%) were influenza B viruses. Of the 102 influenza A viruses that were 
subtyped, 88 (86.3%) were H3N2 viruses and 14 (13.7%) were (H1N1)pdm09 
viruses. 
o The majority of the influenza viruses collected from the United States during 
May 21 through October 28, 2017 were characterized antigenically and 
genetically as being similar to the cell-grown reference viruses representing the 
2017–18 Northern Hemisphere influenza vaccine viruses. 
o None of the viruses tested from May 21-October 28, 2017 were found to be 
resistant to oseltamivir, zanamivir, or peramivir.  
o Three human infections with novel influenza A viruses were reported by 3 states 
(Colorado [1], Nebraska [1], and Michigan [1]) during the week ending October 
28. Two infections were with influenza A(H3N2) variant (H3N2v) viruses and one 
infection was with an influenza A(H1N2) variant (H1N2v) virus.  No ongoing 
human-to-human transmission was identified. 
FluView (http://www.cdc.gov/flu/weekly/fluactivitysurv.htm) is available – and past issues 
are archived (http://www.cdc.gov/flu/weekly/pastreports.htm) – on the CDC website. 
Note: Delays in reporting may mean that data changes over time. The most up to date 
data for all weeks during the 2017-2018 season can be found on the current 
FluView(http://www.cdc.gov/flu/weekly/) and FluView Interactive 
(https://www.cdc.gov/flu/weekly/fluviewinteractive.htm). 
 
Flu-Related Pediatric Deaths  
• This week CDC is reporting a pediatric death that occurred last season (2016-2017) 
during the week ending February 18, 2017. That brings the total number of flu 
pediatric deaths from last season, to 109.  
• Last week, CDC reported the first influenza-associated pediatric death of the 2017-
2018 season.  
o The death occurred during the week ending October 21, 2017 and was 
associated with an influenza (H1N1)pdm09 virus infection.  
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• Since 2004, when pediatric deaths associated with influenza infection became 
nationally notifiable, the number of deaths reported to CDC each year has ranged from 
37 (2011-2012 season) to 171 deaths (2012-2013 season).  
• Additional data about influenza-associated pediatric mortality can be found at: 
http://gis.cdc.gov/GRASP/Fluview/PedFluDeath.html. 
• Because of confidentiality issues, CDC does not discuss or give details on individuals.  
• This death is a somber reminder of the danger flu poses to children.  
• The single best way to protect against seasonal flu and its potentially severe 
consequences in children is to get a seasonal flu vaccine each year.  
• Vaccination is important for children younger than 5 years. It is especially important 
for those younger than 2 years and children of any age with a long-term health 
condition like asthma, diabetes and heart disease and neurological and 
neurodevelopmental diseases. These children are at higher risk of serious flu 
complications if they get the flu. 
• Yearly vaccination also is especially important for people in contact with high risk 
children in order to protect the child (or children) in their lives from the flu. In 
particular, children younger than 6 months are too young to be vaccinated themselves 
but are at high risk of flu complications if they get sick so the people around them 
should get vaccinated to protect the infant. 
• Some children 6 months through 8 years of age require 2 doses of influenza vaccine. 
Children in this age group who are getting vaccinated for the first time will need two 
doses. Some children who have received influenza vaccine previously also will need 
two doses this season. A health care provider should be consulted to determine 
whether two doses are recommended for a child. 
• Flu-related deaths in children younger than 18 years old should be reported through 
the Influenza-Associated Pediatric Mortality Surveillance System. The number of flu-
associated deaths among children reported during the 2017-2018 flu season will be 
updated each week and can be found at www.cdc.gov/flu/weekly/.  
 
 
